CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 13, 2006--Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Henry E. Blair, Chairman, and Chief Executive Officer of Dyax, will present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2006, being held on February 14-15, 2006 at the Waldorf=Astoria Hotel in New York City. Mr. Blair will present a corporate progress report, including an update on the Company's clinical development programs. The Dyax Corp. presentation is scheduled for Wednesday, February 15 at 2:30 pm (EST).
